New CFO for Biotie
27.12.2012 - Finish Biotie Therapy Corp. has appointed David Cook as new Chief Financial Officer effective February 25. Kristian Rantala, current interim CFO, will resume his prior duties as Vice President, Finance and Administration, Finland.
David Cook brings in extensive industry expertise in life science enterprises in finance, strategy, investor relations and M&A. Biotie’s future CFO came in from public US company Jazz Pharmaceuticals, Inc.. Prior to that, Cook was CFO of EUSA Pharma Inc., which was acquired by Jazz Pharmaceuticals in mid-2012. Before joining EUSA, the chemist was Group Financial Controller at Zeneus Pharma Limited and worked with PricewaterhouseCoopers in the United Kingdom and Australia. David is a qualified chartered accountant and graduated from the University of Oxford with a degree in Chemistry.